August 16, 2018
MIPS INTERIM REPORT JANUARY – JUNE 2018
Media
August 16, 2018
Nexstim Plc Half-Yearly Report 1 January – 30 June 2018 (unaudited)
August 16, 2018
BONESUPPORT – CERAMENT® G Approved by Health Canada
August 15, 2018
Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August
August 15, 2018
Strongbridge Biopharma plc Announces Termination of Public Offering of Ordinary Shares
August 14, 2018
Strongbridge Biopharma plc Announces Proposed Public Offering of Ordinary Shares
August 10, 2018
MIPS: Invitation to the presentation of the results for the period January – June 2018
August 09, 2018
Notice of Nexstim Plc’s Half-Yearly Report H1 2018
August 09, 2018
Anders Martin-Löf has been appointed as the new CFO of Oncopeptides
August 08, 2018
Strongbridge Biopharma plc Announces Positive Top-Line Results from the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome
